TCGX is a registered investment advisor based in Palo Alto, California. TCGX invests in both private and public opportunities, focusing on innovative pre-IPO and public drug discovery companies. We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
18
Total Investments
17
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About TCG Crossover
Recent Investments (18)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Post-IPO Equity | •••••• | Jun 2024 | |
| Post-IPO Equity | •••••• | Jun 2024 | |
| Post-IPO Equity | •••••• | Mar 2024 | |
| Post-IPO Equity | •••••• | Feb 2024 | |
| Post-IPO Equity | •••••• | Feb 2024 | |
•••• ••••
|
Post-IPO Equity | •••••• | Jan 2024 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Oct 2023 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Aug 2023 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Aug 2023 |
|
•••• ••••
|
Series F | •••••• | Aug 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
